Mitochondrial stress response gene Clpp deficiency impairs oocyte competence and deteriorate cyclophosphamide-induced ovarian damage in young mice
Frontiers in Endocrinology · 24.03.2023 · 14
DOI: 10.3389/fendo.2023.1122012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Endocrinology, online erschienen am 24.03.2023. Verfasst von Guangxin Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Peking University Shenzhen Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Peptidyl-Dipeptidase A, Oocytes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Chemotherapy is extensively used to treat cancers and is often associated with ovarian damage and leads to premature ovarian insufficiency and infertility, while the role of mitochondria during ovarian damage with chemotherapy remains unknown. This study used a mouse model with oocyte-specific deletion of mitochondrial stress response gene Caseinolytic peptidase P ( Clpp ) to investigate mitochondrial homeostasis in oocytes from mice receiving a chemotherapeutic drug cyclophosphamide (CTX). We found that oocyte-specific deletion of Clpp reduced fecundity of the mice at advanced age. The deletion led to meiotic defects with elevated abnormal spindle rate and aneuploidy rate with impaired mitochondrial function in the MII oocytes from 8-week-old mice. Upon CTX treatment at 8-week-old, the oocyte competence and folliculogenesis from the oocyte-specific Clpp knockout mice was further deteriorated with dramatic impairment of mitochondrial distribution and function including elevated ROS level, decreased mitochondrial membrane potential, respiratory chain activity and ATP production. Taken together, the results indicate that that ClpP was required for oocyte competence during maturation and early folliculogenesis, and its deficiency deteriorate cyclophosphamide-induced ovarian damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast and Thyroid Surgery, Peking University Shenzhen Hospital, Shenzhen, China.
- Shenzhen Key Laboratory of Fertility Regulation, Reproductive Medicine Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
- Department of Obstetrics and Gynaecology, The University of Hong Kong - Shenzhen Hospital, Shenzhen, China.
- Department of Obstetrics and Gynaecology, Li Ka Shing Faculty of Medicine, The University of HongKong, Hong Kong, Hong Kong SAR, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, G., Gu, J., Zhou, X., Wu, T., Li, X., Hua, R., Hai, Z., Xiao, Y., Su, J., Yeung, W. S. B., Liu, K., Guo, C., & Wang, T. (2023). Mitochondrial stress response gene Clpp deficiency impairs oocyte competence and deteriorate cyclophosphamide-induced ovarian damage in young mice. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1122012
Vancouver
Li G, Gu J, Zhou X, Wu T, Li X, Hua R, et al. Mitochondrial stress response gene Clpp deficiency impairs oocyte competence and deteriorate cyclophosphamide-induced ovarian damage in young mice. Frontiers in Endocrinology. 2023;14. doi:10.3389/fendo.2023.1122012
BibTeX
@article{Li2023,
author = {Li, Guangxin and Gu, Jingkai and Zhou, Xiaomei and Wu, Ting and Li, Xian and Hua, Renwu and Hai, Zhuo and Xiao, Yuan and Su, Jiaping and Yeung, Willian S B and Liu, Kui and Guo, Chenxi and Wang, Tianren},
title = {Mitochondrial stress response gene Clpp deficiency impairs oocyte competence and deteriorate cyclophosphamide-induced ovarian damage in young mice},
journal = {Frontiers in Endocrinology},
year = {2023},
volume = {14},
doi = {10.3389/fendo.2023.1122012}
}
EUVIMED